SCHEMBL20334166

SCHEMBL20334166

NNC(=O)C1CCC(n2c(=O)[nH]c3ccccc32)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
MAPK1 P28482 2/20 0.54
CHRM2 P08172 4/20 0.53
CHRM4 P08173 4/20 0.53
CHRM1 P11229 4/20 0.53
CHRM3 P20309 3/20 0.53
HSD11B1 P28845 4/20 0.52
SLC18A3 Q16572 1/20 0.52
OPRM1 P35372 4/20 0.51
OPRK1 P41145 2/20 0.51
OPRL1 P41146 2/20 0.51
PLD2 O14939 2/20 0.51
OPRD1 P41143 1/20 0.51
KDM4E B2RXH2 1/20 0.50
PMP22 Q01453 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
CHRM5 P08912 2/20 0.49
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
PLD1 Q13393 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20302481 1.00 ALDH1A1 (0.54) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL20334017 0.88 HSD11B1 (0.50) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL20302250 0.88 HSD11B1 (0.50) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL29198253 0.84 OPRM1 (0.59) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL29198250 0.84 OPRM1 (0.59) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL319049 0.83 CHRM1 (0.70) CHRM2CHRM4CHRM1CHRM3SLC18A3
SCHEMBL20302189 0.82 CHRM2 (0.55) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL20334172 0.82 CHRM2 (0.55) ALDH1A1MAPK1CHRM2CHRM4CHRM1
SCHEMBL22869746 0.81 KMT2A (0.58) ALDH1A1MAPK1CHRM2CHRM1CHRM3
SCHEMBL28512418 0.81 KMT2A (0.58) ALDH1A1MAPK1CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118868-A1 TRIAZOLE DERIVATIVES AS TANKYRASE INHIBITORS OSLO UNIVERSITY HOSPITAL HF (NO) 2018-06-28 WO disclosed